AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8907100 — intervention group
Group type: EXPERIMENTAL
Intervention: Quit kit plus 1 telephone counseling session
Number of subjects: 3030
Study 8907100 — intervention group
Group type: EXPERIMENTAL
Intervention: Quit kit plus up to 6 telephone counseling sessions
Number of subjects: 3030
Study 8907100 — intervention group
Group type: COMPARATOR
Intervention: Self-help quit kit
Number of subjects: 3030
Study 1986555 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (15-day tapering dose of prednisone: 15, 10, 5 mg) with diuretics (40 mg furosemide and 200 mg spironolactone)
Number of subjects: 37
Study 1986555 — intervention group
Group type: COMPARATOR
Intervention: Control group (diuretics only: 40 mg furosemide and 200 mg spironolactone)
Number of subjects: 37
Study 6851752 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthograde bowel lavage alone (group I)
Number of subjects: 57
Study 6851752 — intervention group
Group type: COMPARATOR
Intervention: Combined bowel lavage and parenteral antibiotic prophylaxis with 4 gm Cefoxitin (group II)
Number of subjects: 57
Study 30922846 — intervention group
Group type: EXPERIMENTAL
Intervention: Major hepatectomy in high-risk group
Number of subjects: 359
Study 30922846 — intervention group
Group type: COMPARATOR
Intervention: Minor hepatectomy in high-risk group
Number of subjects: 359
Study 30922846 — intervention group
Group type: COMPARATOR
Intervention: Extent of hepatectomy in low-risk group
Number of subjects: 359
Study 29079060 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 polyunsaturated fatty acids (PUFA) supplementation (2.2g/d of EPA and DHA)
Number of subjects: 29
Study 29079060 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 29
Study 24325899 — intervention group
Group type: EXPERIMENTAL
Intervention: THUNDERBEAT (TB)
Number of subjects: 50
Study 24325899 — intervention group
Group type: COMPARATOR
Intervention: Standard electrosurgery (SES)
Number of subjects: 50
Study 22256909 — intervention group
Group type: EXPERIMENTAL
Intervention: loteprednol etabonate 0.5%/tobramycin 0.3% (LE/T)
Number of subjects: 308
Study 22256909 — intervention group
Group type: COMPARATOR
Intervention: dexamethasone 0.1%/tobramycin 0.3% (DM/T)
Number of subjects: 308
Study 20332140 — intervention group
Group type: EXPERIMENTAL
Intervention: Triplet chemotherapy
Number of subjects: 443
Study 20332140 — intervention group
Group type: COMPARATOR
Intervention: Standard doublet regimen
Number of subjects: 443
Study 20332140 — intervention group
Group type: EXPERIMENTAL
Intervention: ERCC1-negative status and adenocarcinomas
Number of subjects: 443
Study 16621113 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecare Group (TG) - 12 appointments (9 telematic with GlucoBeep system + 3 ambulatory)
Number of subjects: 40
Study 16621113 — intervention group
Group type: COMPARATOR
Intervention: Conventional Group (CG) - 12 outpatient appointments
Number of subjects: 40
Study 16621113 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost analysis for TG
Number of subjects: 40
Study 12687877 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation
Number of subjects: 32
Study 12687877 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency (RF) procedures
Number of subjects: 32
Study 10924317 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide (8 microg. kg(‐1))
Number of subjects: 150
Study 10924317 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (5 mg. kg(‐1))
Number of subjects: 150
Study 10924317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 8825017 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad spectrum antioxidant capsule (po BID)
Number of subjects: 71
Study 8825017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 1402964 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine for six or 24 months
Number of subjects: 276
Study 1402964 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin for six or 24 months
Number of subjects: 276
Study 1402964 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 276
Study 2998191 — intervention group
Group type: EXPERIMENTAL
Intervention: 37.5 mg of terodiline daily for two 3-week periods
Number of subjects: 24
Study 2998191 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term terodiline treatment (6 months to 3 years)
Number of subjects: 24
Study 2998191 — intervention group
Group type: EXPERIMENTAL
Intervention: Terodiline treatment
Number of subjects: 24
Study 30058839 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mg axitinib
Number of subjects: 72
Study 30058839 — intervention group
Group type: COMPARATOR
Intervention: 400-mg sorafenib
Number of subjects: 72
Study 29164749 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) of calf muscles, twice a week for six weeks (3 × 6 stimulation trains at 30 Hz above individual cramp threshold frequency)
Number of subjects: 19
Study 29164749 — intervention group
Group type: COMPARATOR
Intervention: Control leg (unstimulated)
Number of subjects: 19
Study 29164749 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) of calf muscles
Number of subjects: 19
Study 26984138 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing counseling session
Number of subjects: 53
Study 24368315 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran extract (WBE) at 5.0 g/day for 3 weeks
Number of subjects: 29
Study 24368315 — intervention group
Group type: COMPARATOR
Intervention: Control (0 g/day WBE)
Number of subjects: 29
Study 22390710 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-evaluative threat condition (SET; n = 86)
Number of subjects: 144
Study 22390710 — intervention group
Group type: COMPARATOR
Intervention: Nonexplicit social-evaluative threat condition (ne-SET; n = 58)
Number of subjects: 144
Study 22390710 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-evaluative threat condition (SET)
Number of subjects: 144
Study 20498613 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (music-based imagery and music alternate engagement)
Number of subjects: 29
Study 20498613 — intervention group
Group type: COMPARATOR
Intervention: Control (no music)
Number of subjects: 29
Study 18608977 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed forgetting instruction (to remember)
Number of subjects: 21
Study 18608977 — intervention group
Group type: COMPARATOR
Intervention: Directed forgetting instruction (to forget)
Number of subjects: 21
Study 16052582 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg abatacept
Number of subjects: 339
Study 16052582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 339
Study 12124547 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (G-2)
Number of subjects: 26
Study 12124547 — intervention group
Group type: COMPARATOR
Intervention: Control (G-1)
Number of subjects: 26
Study 10626341 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinopril (lisinopril) 10-40 mg daily for 8 weeks
Number of subjects: 0
Study 10626341 — intervention group
Group type: COMPARATOR
Intervention: Captopril (capoten) 25-100 mg daily for 8 weeks
Number of subjects: 0
Study 10626341 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs (Sinopril and Captopril)
Number of subjects: 0
Study 7540856 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF at 10 micrograms/kg/d after cyclophosphamide 4 g/m2 i.v.
Number of subjects: 22
Study 7540856 — intervention group
Group type: COMPARATOR
Intervention: rhG-CSF at 10 micrograms/kg/d after cyclophosphamide 4 g/m2 i.v.
Number of subjects: 22
Study 1952777 — intervention group
Group type: EXPERIMENTAL
Intervention: Long acting nitroglycerin
Number of subjects: 20
Study 1952777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6259740 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A: surgery + chemotherapy alone (60 patients)
Number of subjects: 137
Study 6259740 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B: surgery + radiotherapy + chemotherapy (22 patients)
Number of subjects: 137
Study 6259740 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol C: surgery + chemotherapy (4 cycles) + radiotherapy + chemotherapy (51 patients)
Number of subjects: 137
Study 31100756 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic medicines prescribed with consideration of individual temperament (temperament(+))
Number of subjects: 50
Study 31100756 — intervention group
Group type: COMPARATOR
Intervention: Homeopathic medicines prescribed without consideration of individual temperament (temperament(-))
Number of subjects: 50
Study 28183546 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (VIMA)
Number of subjects: 124
Study 28183546 — intervention group
Group type: COMPARATOR
Intervention: Propofol (TIVA)
Number of subjects: 124
Study 25720624 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent (ZES)
Number of subjects: 1606
Study 25720624 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1606
Study 24403903 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle changes (healthy diet and physical activity advice)
Number of subjects: 108
Study 24403903 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (100 ml for women, 200 ml for men daily)
Number of subjects: 108
Study 24403903 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lifestyle changes)
Number of subjects: 108
Study 21146420 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 deep breaths hourly
Number of subjects: 181
Study 21146420 — intervention group
Group type: COMPARATOR
Intervention: 10 deep breaths hourly
Number of subjects: 181
Study 19693752 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 % sodium chondroitin sulfate (Gepan instill)
Number of subjects: 82
Study 19693752 — intervention group
Group type: COMPARATOR
Intervention: Anticholinergic treatment (Tolterodin)
Number of subjects: 82
Study 18026577 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacilli-fermented milk
Number of subjects: 89
Study 18026577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 15662902 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline recommendations for the diagnosis, treatment, and management of infectious endocarditis
Number of subjects: 0
Study 15662902 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 11142543 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional child psychotherapy
Number of subjects: 53
Study 11142543 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no specific intervention mentioned)
Number of subjects: 53
Study 9487784 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-administered version of the Freiburg Personality Inventory (FPI-R)
Number of subjects: 600
Study 9487784 — intervention group
Group type: COMPARATOR
Intervention: Standard paper-pencil questionnaire
Number of subjects: 600
Study 9487784 — intervention group
Group type: EXPERIMENTAL
Intervention: Homogeneous item blocking
Number of subjects: 600
Study 9487784 — intervention group
Group type: COMPARATOR
Intervention: Standard item arrangement
Number of subjects: 600
Study 8267694 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperimmune globulin (HIg) prophylaxis administered from week 1 until week 7 after transplantation
Number of subjects: 28
Study 8267694 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HIg prophylaxis)
Number of subjects: 28
Study 3765736 — intervention group
Group type: EXPERIMENTAL
Intervention: Running group
Number of subjects: 48
Study 3765736 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming group
Number of subjects: 48
Study 3765736 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergometer group
Number of subjects: 48
Study 3765736 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 30129691 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive smartphone data (physical mobility)
Number of subjects: 271
Study 30129691 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized models combining features
Number of subjects: 271
Study 30027283 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-holding
Number of subjects: 135
Study 30027283 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress ball
Number of subjects: 135
Study 30027283 — intervention group
Group type: COMPARATOR
Intervention: Control (treatment as usual)
Number of subjects: 135
Study 27585728 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-recorded hypnosis with background music
Number of subjects: 75
Study 27585728 — intervention group
Group type: EXPERIMENTAL
Intervention: Music without hypnosis
Number of subjects: 75
Study 27585728 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 24582914 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab (CAPOX-C)
Number of subjects: 149
Study 24582914 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine plus oxaliplatin (CAPOX)
Number of subjects: 149
Study 23089983 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 183
Study 20103209 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip procedure
Number of subjects: 107
Study 18834364 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam-beta-cyclodextrin sachets (20 mg daily for 28 days)
Number of subjects: 42
Study 18834364 — intervention group
Group type: COMPARATOR
Intervention: Piroxicam tablets (20 mg daily for 28 days)
Number of subjects: 42
Study 18834364 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (sachet and tablets)
Number of subjects: 42
Study 15947773 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler transthoracic echocardiography
Number of subjects: 84
Study 11821652 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief physician advice intervention consisting of two physician visits and two nurse follow-up phone calls.
Number of subjects: 774
Study 11821652 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 382).
Number of subjects: 774
Study 11821652 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief physician advice intervention.
Number of subjects: 774
Study 12412497 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior with explicit evidence of intent
Number of subjects: 1080
Study 12412497 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior with greater degree of persistence
Number of subjects: 1080
Study 12412497 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender (female vs male)
Number of subjects: 1080
Study 12412497 — intervention group
Group type: EXPERIMENTAL
Intervention: General community perception
Number of subjects: 1080
Study 9701410 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 24 microg b.i.d. (by Turbuhaler)
Number of subjects: 110
Study 9701410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 8029513 — intervention group
Group type: EXPERIMENTAL
Intervention: topical zinc ointment
Number of subjects: 58
Study 8029513 — intervention group
Group type: COMPARATOR
Intervention: placebo ointment
Number of subjects: 58
Study 2532461 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 to 5 mg once daily
Number of subjects: 450
Study 30965072 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized music therapy (MT) for 15 minutes prior to EEG session (Group 2)
Number of subjects: 64
Study 30965072 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized music therapy (MT) for 15 minutes prior to EEG session plus rubber cap for home practice (Group 3)
Number of subjects: 64
Study 30965072 — intervention group
Group type: COMPARATOR
Intervention: No preparation (Group 1)
Number of subjects: 64
Study 30965072 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized music therapy (MT) procedural support during EEG session for all groups
Number of subjects: 64
Study 28332851 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment
Number of subjects: 126
Study 28332851 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 126
Study 25066733 — intervention group
Group type: EXPERIMENTAL
Intervention: IV n-3PUFA emulsion (0.6 g/kg body weight)
Number of subjects: 8
Study 25066733 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral n-3PUFA (0.6 g/kg over 3 consecutive days)
Number of subjects: 8
Study 25066733 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet function tests
Number of subjects: 8
Study 25066733 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA and DHA membrane contents of RBC and platelets
Number of subjects: 8
Study 22618304 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance Training (HIT)
Number of subjects: 19
Study 22618304 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Blood Flow-Restricted Resistance Training (LI-BFR)
Number of subjects: 19
Study 22618304 — intervention group
Group type: COMPARATOR
Intervention: Control Group (not explicitly mentioned)
Number of subjects: 19
Study 21399726 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerian officinalis 450 mg orally 1 hour before bedtime for 8 weeks
Number of subjects: 227
Study 21399726 — intervention group
Group type: COMPARATOR
Intervention: Placebo orally 1 hour before bedtime for 8 weeks
Number of subjects: 227
Study 21399726 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerian officinalis 450 mg
Number of subjects: 227
Study 21399726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study 21399726 — intervention group
Group type: COMPARATOR
Intervention: Valerian and Placebo
Number of subjects: 227
Study 18562424 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine (average dose 103.5 mg/day)
Number of subjects: 0
Study 18562424 — intervention group
Group type: COMPARATOR
Intervention: Tricyclic Antidepressants (TCAs) (average dose 106.1 mg/day)
Number of subjects: 0
Study 18562424 — intervention group
Group type: COMPARATOR
Intervention: Tricyclic Antidepressants (TCAs)
Number of subjects: 0
Study 17039666 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of apple polyphenols
Number of subjects: 33
Study 17039666 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of apple polyphenols
Number of subjects: 33
Study 17039666 — intervention group
Group type: COMPARATOR
Intervention: Control group (no apple polyphenols)
Number of subjects: 33
Study 14701886 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated management approach (early clinical review, education sessions, personal diary for medications and weight, regular clinical follow-up alternating between GP and hospital clinic)
Number of subjects: 197
Study 14701886 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 197
Study 14701886 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated management approach
Number of subjects: 197
Study 10688389 — intervention group
Group type: EXPERIMENTAL
Intervention: nabumetone 2000 mg/d
Number of subjects: 346
Study 10688389 — intervention group
Group type: COMPARATOR
Intervention: naproxen 1000 mg/d
Number of subjects: 346
Study 9357406 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium (2 g bolus, followed by 8 g over 24 h)
Number of subjects: 156
Study 9357406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 8230367 — intervention group
Group type: EXPERIMENTAL
Intervention: Walkman music during epidural anesthesia
Number of subjects: 120
Study 8230367 — intervention group
Group type: COMPARATOR
Intervention: Non-music group
Number of subjects: 120
Study 31876030 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent support groups for people living with rare dementia
Number of subjects: 1000
Study 31876030 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-methods design including longitudinal cohort study and feasibility RCT
Number of subjects: 1000
Study 31876030 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative methods including thematic analysis (TA)
Number of subjects: 1000
Study 31876030 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative analytical methods involving the arts as a research method
Number of subjects: 1000
Study 30932161 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 44
Study 30932161 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 44
Study 28283760 — intervention group
Group type: EXPERIMENTAL
Intervention: Shiatsu plus amitriptyline
Number of subjects: 37
Study 28283760 — intervention group
Group type: EXPERIMENTAL
Intervention: Shiatsu alone
Number of subjects: 37
Study 28283760 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline alone
Number of subjects: 37
Study 28283760 — intervention group
Group type: EXPERIMENTAL
Intervention: Shiatsu (alone or in combination)
Number of subjects: 37
Study 26439070 — intervention group
Group type: EXPERIMENTAL
Intervention: SF with touch
Number of subjects: 122
Study 26439070 — intervention group
Group type: EXPERIMENTAL
Intervention: SF with arms' restraint
Number of subjects: 122
Study 26439070 — intervention group
Group type: COMPARATOR
Intervention: Standard SF
Number of subjects: 122
Study 24013651 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab
Number of subjects: 34
Study 21793278 — intervention group
Group type: EXPERIMENTAL
Intervention: Exteriorized repair
Number of subjects: 338
Study 21793278 — intervention group
Group type: COMPARATOR
Intervention: In situ repair
Number of subjects: 338
Study 19259112 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimicronutrient (MMN) supplementation for 1 year
Number of subjects: 293
Study 19259112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study 17077240 — intervention group
Group type: EXPERIMENTAL
Intervention: CA 125 and transvaginal ultrasonography screening
Number of subjects: 28460
Study 14695733 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg intravenous M6G
Number of subjects: 20
Study 14695733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11240595 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 12
Study 11240595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9863106 — intervention group
Group type: EXPERIMENTAL
Intervention: Jinshui Liujun decoction (JSL)
Number of subjects: 0
Study 9863106 — intervention group
Group type: COMPARATOR
Intervention: Normal saline control group
Number of subjects: 0